Nothing Special   »   [go: up one dir, main page]
IDEAS home Printed from https://ideas.repec.org/e/pph37.html
   My authors  Follow this author

Tomas Philipson

Personal Details

First Name:Tomas
Middle Name:J
Last Name:Philipson
Suffix:
RePEc Short-ID:pph37
[This author has chosen not to make the email address public]
http://harrisschool.uchicago.edu/faculty/web-pages/tomas-philipson.asp
Terminal Degree:1989 Wharton School of Business; University of Pennsylvania (from RePEc Genealogy)

Affiliation

(50%) Leonard D. Schaeffer Center for Health Policy and Economics
University of Southern California

Los Angeles, California (United States)
http://healthpolicy.usc.edu/
RePEc:edi:chuscus (more details at EDIRC)

(1%) National Bureau of Economic Research (NBER)

Cambridge, Massachusetts (United States)
http://www.nber.org/
RePEc:edi:nberrus (more details at EDIRC)

(49%) Harris School of Public Policy
University of Chicago

Chicago, Illinois (United States)
http://harris.uchicago.edu/
RePEc:edi:spuchus (more details at EDIRC)

Research output

as
Jump to: Working papers Articles Chapters Books

Working papers

  1. Adam Jørring & Andrew W. Lo & Tomas J. Philipson & Manita Singh & Richard T. Thakor, 2017. "Sharing R&D Risk in Healthcare via FDA Hedges," NBER Working Papers 23344, National Bureau of Economic Research, Inc.
  2. Kristopher J. Hult & Sonia Jaffe & Tomas J. Philipson, 2016. "How Does Technological Change Affect Quality-Adjusted Prices in Health Care? Systematic Evidence from Thousands of Innovations," NBER Working Papers 22986, National Bureau of Economic Research, Inc.
  3. Mark Egan & Tomas J. Philipson, 2014. "Health Care Adherence and Personalized Medicine," NBER Working Papers 20330, National Bureau of Economic Research, Inc.
  4. Ralph Koijen & Tomas Philipson & Harald Uhlig, 2014. "Financial Health Economics," NBER Working Papers 20075, National Bureau of Economic Research, Inc.
  5. Egan, Mark L. & Mulligan, Casey B. & Philipson, Tomas J., 2013. "Adjusting Measures of Economic Output for Health: Is the Business Cycle Countercyclical?," Working Papers 246, The University of Chicago Booth School of Business, George J. Stigler Center for the Study of the Economy and the State.
  6. Mark L. Egan & Casey B. Mulligan & Tomas J. Philipson, 2013. "Adjusting National Accounting for Health: Is the Business Cycle Countercyclical?," NBER Working Papers 19058, National Bureau of Economic Research, Inc.
  7. Tomas J. Philipson & George Zanjani, 2013. "Economic Analysis of Risk and Uncertainty induced by Health Shocks: A Review and Extension," NBER Working Papers 19005, National Bureau of Economic Research, Inc.
  8. Mark Egan & Tomas J. Philipson, 2013. "International Health Economics," NBER Working Papers 19280, National Bureau of Economic Research, Inc.
  9. Kristopher J. Hult & Tomas J. Philipson, 2012. "Public Liabilities and Health Care Policy," NBER Working Papers 18571, National Bureau of Economic Research, Inc.
  10. Anup Malani & Tomas J. Philipson, 2011. "Can Medical Progress be Sustained? Implications of the Link Between Development and Output Markets," NBER Working Papers 17011, National Bureau of Economic Research, Inc.
  11. Tomas J. Philipson & Gary Becker & Dana Goldman & Kevin M. Murphy, 2010. "Terminal Care and The Value of Life Near Its End," NBER Working Papers 15649, National Bureau of Economic Research, Inc.
  12. Anirban Basu & Tomas J. Philipson, 2010. "The Impact of Comparative Effectiveness Research on Health and Health Care Spending," NBER Working Papers 15633, National Bureau of Economic Research, Inc.
  13. Tomas J. Philipson & Eric C. Sun & Dana Goldman, 2009. "The Effects of Product Liability Exemption in the Presence of the FDA," NBER Working Papers 15603, National Bureau of Economic Research, Inc.
  14. Eric C. Sun & Anupam B. Jena & Darius N. Lakdawalla & Carolina M. Reyes & Tomas J. Philipson & Dana P. Goldman, 2009. "An Economic Evaluation of the War on Cancer," NBER Working Papers 15574, National Bureau of Economic Research, Inc.
  15. Anupam Jena & Tomas Philipson, 2009. "Endogenous Cost-Effectiveness Analysis in Health Care Technology Adoption," NBER Working Papers 15032, National Bureau of Economic Research, Inc.
  16. Anupam Jena & Casey Mulligan & Tomas J. Philipson & Eric Sun, 2008. "The Value of Life in General Equilibrium," NBER Working Papers 14157, National Bureau of Economic Research, Inc.
  17. Tomas Philipson & Richard Posner, 2008. "Is the Obesity Epidemic a Public Health Problem? A Decade of Research on the Economics of Obesity," NBER Working Papers 14010, National Bureau of Economic Research, Inc.
  18. Philipson, Tomas J. & Berndt, Ernst R. & Gottschalk, Adrian H. B. & Sun, Eric, 2007. "Cost-Benefit Analysis of the FDA: The Case of the Prescription Drug User Fee Acts," Working Papers 217, The University of Chicago Booth School of Business, George J. Stigler Center for the Study of the Economy and the State.
  19. Dana Goldman & Tomas Philipson, 2007. "Integrated Insurance Design in the Presence of Multiple Medical Technologies," NBER Working Papers 12870, National Bureau of Economic Research, Inc.
  20. Gary Becker & Kevin Murphy & Tomas Philipson, 2007. "The Value of Life Near its End and Terminal Care," Levine's Working Paper Archive 122247000000001428, David K. Levine.
  21. Tomas J. Philipson & Eric Sun, 2007. "Is the Food and Drug Administration Safe and Effective?," NBER Working Papers 13561, National Bureau of Economic Research, Inc.
  22. Tomas Philipson & Stephane Mechoulan & Anupam Jena, 2006. "Health Care, Technological Change, and Altruistic Consumption Externalities," NBER Working Papers 11930, National Bureau of Economic Research, Inc.
  23. Tomas J. Philipson & Anupam B. Jena, 2006. "Surplus Appropriation from R&D and Health Care Technology Assessment Procedures," NBER Working Papers 12016, National Bureau of Economic Research, Inc.
  24. Darius Lakdawalla & Tomas Philipson & Y. Richard Wang, 2006. "Intellectual Property and Marketing," NBER Working Papers 12577, National Bureau of Economic Research, Inc.
  25. Tomas J. Philipson & Richard A. Posner, 2006. "Antitrust in the Not-For-Profit Sector," NBER Working Papers 12132, National Bureau of Economic Research, Inc.
  26. Tomas J. Philipson & Anupam B. Jena, 2005. "Who Benefits from New Medical Technologies? Estimates of Consumer and Producer Surpluses for HIV/AIDS Drugs," NBER Working Papers 11810, National Bureau of Economic Research, Inc.
  27. Tomas J. Philipson & Ernst R. Berndt & Adrian H. B. Gottschalk & Matthew W. Strobeck, 2005. "Assessing the Safety and Efficacy of the FDA: The Case of the Prescription Drug User Fee Acts," NBER Working Papers 11724, National Bureau of Economic Research, Inc.
  28. Philipson, Tomas J. & Mechoulan, Stéphane, 2005. "Intellectual Property & External Consumption Effects: Generalizations From Health Care Markets," Working Papers 198, The University of Chicago Booth School of Business, George J. Stigler Center for the Study of the Economy and the State.
  29. Ernst R. Berndt & Adrian H. B. Gottschalk & Tomas Philipson & Matthew W. Strobeck, 2004. "Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process," NBER Working Papers 10822, National Bureau of Economic Research, Inc.
  30. Tomas Philipson & Stephane Mechoulan, 2003. "Intellectual Property & External Consumption Effects: Generalizations from Pharmaceutical Markets," NBER Working Papers 9598, National Bureau of Economic Research, Inc.
  31. Gary S. Becker & Tomas J. Philipson & Rodrigo R. Soares, 2003. "The Quantity and Quality of Life and the Evolution of World Inequality," NBER Working Papers 9765, National Bureau of Economic Research, Inc.
  32. Darius Lakdawalla & Tomas Philipson, 2002. "The Growth of Obesity and Technological Change: A Theoretical and Empirical Examination," Working Papers 0203, Harris School of Public Policy Studies, University of Chicago.
  33. Frank R. Lichtenberg & Tomas J. Philipson, 2002. "The Dual Effects of Intellectual Property Regulations: Within- and Between-Patent Competition in the US," Working Papers 0209, Harris School of Public Policy Studies, University of Chicago.
  34. Frank R. Lichtenberg & Tomas J. Philipson, 2002. "The Dual Effects of Intellectual Property Regulations: Within- and Between- Patent Competition in the US Pharmaceuticals Industry," NBER Working Papers 9303, National Bureau of Economic Research, Inc.
  35. Mulligan, Casey B. & Philipson, Tomas J., 2000. "Merit Motives & Government Intervention: Public Finance in Reverse," Working Papers 159, The University of Chicago Booth School of Business, George J. Stigler Center for the Study of the Economy and the State.
  36. Tomas Philipson, 1999. "Economic Epidemiology and Infectious Diseases," NBER Working Papers 7037, National Bureau of Economic Research, Inc.
  37. Darius Lakdawalla & Tomas Philipson, 1999. "Aging and the Growth of Long-Term Care," Working Papers 9909, Harris School of Public Policy Studies, University of Chicago.
  38. Tomas J. Philipson & Richard A. Posner, 1999. "The Long-Run Growth in Obesity as a Function of Technological Change," Working Papers 9912, Harris School of Public Policy Studies, University of Chicago.
  39. Tomas Philipson, 1999. "External Treatment Effects and Program Implementation Bias," Working Papers 9929, Harris School of Public Policy Studies, University of Chicago.
  40. Geoffard, P.Y. & Philipson, T., 1998. "Data MArkets and OPtimal Sample Size Determination," DELTA Working Papers 98-15, DELTA (Ecole normale supérieure).
  41. Darius Lakdawalla & Tomas Philipson, 1998. "The Rise in Old Age Longevity and the Market for Long-Term Care," NBER Working Papers 6547, National Bureau of Economic Research, Inc.
  42. Geoffard, P.Y. & Philipson, T., 1998. "Pricing and R&D with Related Margins," DELTA Working Papers 98-14, DELTA (Ecole normale supérieure).
  43. Darius Lakdawalla & Tomas Philipson, 1998. "Nonprofit Production and Competition," NBER Working Papers 6377, National Bureau of Economic Research, Inc.
  44. Tomas Philipson & George Zanjani, 1997. "Consumption vs. Production of Insurance," NBER Working Papers 6225, National Bureau of Economic Research, Inc.
  45. William H. Dow & Tomas Philipson & Xavier Sala-i-Martin & Jessica Holmes, 1997. "Health investment complementarities under competing risks," Economics Working Papers 192, Department of Economics and Business, Universitat Pompeu Fabra.
  46. Mullin, Charles & Philipson, Tomas J., 1997. "The Future of Old-Age Longevity: Competitive Pricing of Morality Contingent Claims," Working Papers 134, The University of Chicago Booth School of Business, George J. Stigler Center for the Study of the Economy and the State.
  47. Mullin, Charles & Philipson, Tomas J., 1997. "The Future of Old-Age Longevity: Competitive Pricing of Morality Contingent Claims," Working Papers 134, The University of Chicago Booth School of Business, George J. Stigler Center for the Study of the Economy and the State.
  48. Tomas Philipson, 1997. "Observational Agency and Supply-Side Econometrics," NBER Technical Working Papers 0210, National Bureau of Economic Research, Inc.
  49. Boozer, M. & Philipson, T., 1996. "The Private Demand for Information and the Effects of Public Testing Programs: The Case of HIV," Papers 750, Yale - Economic Growth Center.
  50. Philipson, Tomas J. & Becker, Gary S., 1996. "Mortality Contingent Claims, Health Care, and Social Insurance," Working Papers 129, The University of Chicago Booth School of Business, George J. Stigler Center for the Study of the Economy and the State.
  51. John Cawley & Tomas Philipson, 1996. "An Empirical Examination of Information Barriers to Trade in Insurance," NBER Working Papers 5669, National Bureau of Economic Research, Inc.
  52. Philipson, Tomas J. & Becker, Gary S., 1996. "Mortality Contingent Claims, Health Care, and Social Insurance," Working Papers 129, The University of Chicago Booth School of Business, George J. Stigler Center for the Study of the Economy and the State.
  53. Geoffard, P.Y. & Philipson, T., 1995. "Rational Epidemics and their Public Control," DELTA Working Papers 95-15, DELTA (Ecole normale supérieure).
  54. William H. Dow & Jessica Holmes & Tomas Philipson & Xavier Sala-i-Martin, 1995. "Disease Complementarities and the Evaluation of Public Health Interventions," NBER Working Papers 5216, National Bureau of Economic Research, Inc.
  55. Geoffard, P.Y. & Philipson, T., 1995. "Disease Eradication: Private vs. Public Vaccination," DELTA Working Papers 95-09, DELTA (Ecole normale supérieure).
  56. Holmes, Jessica & Philipson, Tomas & Sala-i-Martin, Xavier & Tahvonen, Olli, 1995. "Death, Tetanus and Aerobics: The Evaluation of Disease-Specific Health Interventions," CEPR Discussion Papers 1283, C.E.P.R. Discussion Papers.

    repec:fth:chices:146 is not listed on IDEAS
  57. Tomas J. Philipson, "undated". "Self-Interested Treatment Evaluation in Experiments," University of Chicago - Population Research Center 95-1, Chicago - Population Research Center.
  58. Larry V. Hedges & Tomas Philipson, "undated". "Is Health Care Technology Over-Approved? A Meta-Analysis of Revealed Preference," University of Chicago - Population Research Center 95-8, Chicago - Population Research Center.
  59. Avner Ahituv & V. Joseph Hotz & Tomas Philipson, "undated". "Will the AIDS Epidemic be Self-Limiting? Evidence on the Responsiveness of the Demand for Condoms to the Prevalence of AIDS," University of Chicago - Population Research Center 93-3, Chicago - Population Research Center.

    repec:fth:chices:132 is not listed on IDEAS
  60. Casey Mulligan & Tomas Philipson, "undated". "Merit Motives and Government Intervention: Public Finance in Reverse," University of Chicago - Population Research Center 2000-03, Chicago - Population Research Center.
  61. Tomas Philipson & Darius Lakdawalla, "undated". "Nonprofit Production," University of Chicago - Population Research Center 97-8, Chicago - Population Research Center.
  62. Tomas Philipson & Edward Vytlacil, "undated". "Estimating the Extent of Trade Under Incomplete Information: The Case of HIV," University of Chicago - Population Research Center 94-8, Chicago - Population Research Center.

Articles

  1. Adam Jørring & Andrew W Lo & Tomas J Philipson & Manita Singh & Richard T Thakor, 2022. "Sharing R&D Risk in Healthcare via FDA Hedges [Bank lines of credit as contingent liquidity: Covenant violations and their implications]," The Review of Corporate Finance Studies, Society for Financial Studies, vol. 11(4), pages 880-922.
  2. Anup Malani & Tomas J. Philipson, 2019. "Labor Markets in Statistics: The Subject Supply Effect in Medical R&D," Journal of Human Capital, University of Chicago Press, vol. 13(2), pages 293-340.
  3. Kristopher J. Hult & Sonia Jaffe & Tomas J. Philipson, 2018. "How Does Technological Change Affect Quality-Adjusted Prices in Health Care? Systematic Evidence from Thousands of Innovations," American Journal of Health Economics, MIT Press, vol. 4(4), pages 433-453, Fall.
  4. Tomas J. Philipson & Sachin Kamal-Bahl & Anupam B. Jena, 2017. "Defining Value: The Need for a Longer, Broader View," PharmacoEconomics, Springer, vol. 35(7), pages 669-672, July.
  5. Ralph S. J. Koijen & Tomas J. Philipson & Harald Uhlig, 2016. "Financial Health Economics," Econometrica, Econometric Society, vol. 84, pages 195-242, January.
  6. Seabury Seth A. & Goldman Dana P. & Gupta Charu N. & Khan Zeba M. & Chandra Amitabh & Philipson Tomas J. & Lakdawalla Darius N., 2016. "Quantifying Gains in the War on Cancer Due to Improved Treatment and Earlier Detection," Forum for Health Economics & Policy, De Gruyter, vol. 19(1), pages 141-156, June.
  7. Lakdawalla Darius N. & Snider Julia Thornton & Perlroth Daniella J. & LaVallee Chris & Linthicum Mark T. & Philipson Tomas J. & Partridge Jamie S. & Wischmeyer Paul E., 2014. "Can Oral Nutritional Supplements Improve Medicare Patient Outcomes in the Hospital?," Forum for Health Economics & Policy, De Gruyter, vol. 17(2), pages 131-151, September.
  8. Anirban Basu & Anupam B. Jena & Dana P. Goldman & Tomas J. Philipson & Robert Dubois, 2014. "Response To Epstein'S Comment On “Heterogeneity In Action”," Health Economics, John Wiley & Sons, Ltd., vol. 23(3), pages 376-378, March.
  9. Anirban Basu & Anupam B. Jena & Dana P. Goldman & Tomas J. Philipson & Robert Dubois, 2014. "Heterogeneity In Action: The Role Of Passive Personalization In Comparative Effectiveness Research," Health Economics, John Wiley & Sons, Ltd., vol. 23(3), pages 359-373, March.
  10. Stevens Warren & Philipson Tomas & Wu Yanyu & Chen Connie & Lakdawalla Darius, 2014. "A Cost-Benefit Analysis of Using Evidence of Effectiveness in Terms of Progression Free Survival in Making Reimbursement Decisions on New Cancer Therapies," Forum for Health Economics & Policy, De Gruyter, vol. 17(1), pages 21-52, January.
  11. Jena, Anupam B. & Philipson, Tomas J., 2013. "Endogenous cost-effectiveness analysis and health care technology adoption," Journal of Health Economics, Elsevier, vol. 32(1), pages 172-180.
  12. Jena Anupam B. & Mechoulan Stéphane & Philipson Tomas J., 2013. "Should Global Health be Tailored Toward the Rich? Altruism and Efficient R&D for Neglected Diseases," Forum for Health Economics & Policy, De Gruyter, vol. 16(1), pages 83-99, March.
  13. Sood Neeraj & Philipson Tomas J. & Huckfeldt Peter, 2013. "Quantifying the Value of Personalized Medicines: Evidence from COX-2 Inhibitors," Forum for Health Economics & Policy, De Gruyter, vol. 16(1), pages 101-122, April.
  14. Goldman Dana P. & Gupta Charu & Vasudeva Eshan & Trakas Kostas & Riley Ralph & Lakdawalla Darius & Agus David & Sood Neeraj & Jena Anupam B. & Philipson Tomas J., 2013. "The Value of Diagnostic Testing in Personalized Medicine," Forum for Health Economics & Policy, De Gruyter, vol. 16(2), pages 87-99, September.
  15. Philipson Tomas J. & Sun Eric & Goldman Dana & Jena Anupam B., 2012. "A Reexamination of the Costs of Medical R&D Regulation," Forum for Health Economics & Policy, De Gruyter, vol. 15(1), pages 1-28, October.
  16. Thornton Snider Julia & Romley John A. & Vogt William B. & Philipson Tomas J., 2012. "The Option Value of Innovation," Forum for Health Economics & Policy, De Gruyter, vol. 15(1), pages 1-19, April.
  17. Darius Lakdawalla & Tomas Philipson, 2012. "Does Intellectual Property Restrict Output? An Analysis of Pharmaceutical Markets," Journal of Law and Economics, University of Chicago Press, vol. 55(1), pages 151-187.
  18. Basu, Anirban & Jena, Anupam B. & Philipson, Tomas J., 2011. "The impact of comparative effectiveness research on health and health care spending," Journal of Health Economics, Elsevier, vol. 30(4), pages 695-706, July.
  19. Tomas J. Philipson & Seth A. Seabury & Lee M. Lockwood & Dana P. Goldman & Darius N. Lakdawalla, 2010. "Geographic Variation in Health Care: The Role of Private Markets," Brookings Papers on Economic Activity, Economic Studies Program, The Brookings Institution, vol. 41(1 (Spring), pages 325-361.
  20. Anupam B. Jena & Stéphane Mechoulan & Tomas J. Philipson, 2010. "Altruism and Innovation in Health Care," Journal of Law and Economics, University of Chicago Press, vol. 53(3), pages 497-518.
  21. Armineh Zohrabian & Tomas J Philipson, 2010. "External Costs of Risky Health Behaviors Associated with Leading Actual Causes of Death in the U.S.: A Review of the Evidence and Implications for Future Research," IJERPH, MDPI, vol. 7(6), pages 1-13, June.
  22. Lakdawalla, Darius N. & Sun, Eric C. & Jena, Anupam B. & Reyes, Carolina M. & Goldman, Dana P. & Philipson, Tomas J., 2010. "An economic evaluation of the war on cancer," Journal of Health Economics, Elsevier, vol. 29(3), pages 333-346, May.
  23. Sun Eric & Jena Anupam B & Lakdawalla Darius & Reyes Carolina & Philipson Tomas J & Goldman Dana, 2010. "The Contributions of Improved Therapy and Earlier Detection to Cancer Survival Gains, 1988-2000," Forum for Health Economics & Policy, De Gruyter, vol. 13(2), pages 1-22, February.
  24. Dana Goldman & Darius Lakdawalla & Tomas J. Philipson & Wesley Yin, 2010. "Erratum: Valuing health technologies at NICE: recommendations for improved incorporation of treatment value in HTA," Health Economics, John Wiley & Sons, Ltd., vol. 19(12), pages 1510-1510, December.
  25. Dana Goldman & Darius Lakdawalla & Tomas J. Philipson & Wesley Yin, 2010. "Valuing health technologies at nice: recommendations for improved incorporation of treatment value in HTA," Health Economics, John Wiley & Sons, Ltd., vol. 19(10), pages 1109-1116, October.
  26. Tomas J. Philipson & Richard A. Posner, 2009. "Antitrust in the Not-for-Profit Sector," Journal of Law and Economics, University of Chicago Press, vol. 52(1), pages 1-18, February.
  27. Lakdawalla, Darius & Philipson, Tomas, 2009. "The growth of obesity and technological change," Economics & Human Biology, Elsevier, vol. 7(3), pages 283-293, December.
  28. Jena Anupam B & Calfee John E. & Mansley Edward C & Philipson Tomas J, 2009. "`Me-Too' Innovation in Pharmaceutical Markets," Forum for Health Economics & Policy, De Gruyter, vol. 12(1), pages 1-21, November.
  29. Tomas J. Philipson & Eric Sun, 2008. "Is the Food And Drug Administration Safe And Effective?," Journal of Economic Perspectives, American Economic Association, vol. 22(1), pages 85-102, Winter.
  30. Tomas J. Philipson & Richard A. Posner, 2008. "Is the Obesity Epidemic a Public Health Problem? A Review of Zoltan J. Acs and Alan Lyles's Obesity, Business and Public Policy," Journal of Economic Literature, American Economic Association, vol. 46(4), pages 974-982, December.
  31. Philipson, Tomas & Berndt, Ernst R. & Gottschalk, Adrian H.B. & Sun, Eric, 2008. "Cost-benefit analysis of the FDA: The case of the prescription drug user fee acts," Journal of Public Economics, Elsevier, vol. 92(5-6), pages 1306-1325, June.
  32. Jena, Anupam B. & Philipson, Tomas J., 2008. "Cost-effectiveness analysis and innovation," Journal of Health Economics, Elsevier, vol. 27(5), pages 1224-1236, September.
  33. Tomas J. Philipson, 2007. "Commentary," Managerial and Decision Economics, John Wiley & Sons, Ltd., vol. 28(4-5), pages 453-454.
  34. Tomas J. Philipson, 2007. "Commentary," Managerial and Decision Economics, John Wiley & Sons, Ltd., vol. 28(4-5), pages 437-438.
  35. Tomas J. Philipson, 2007. "Commentary," Managerial and Decision Economics, John Wiley & Sons, Ltd., vol. 28(4-5), pages 467-468.
  36. Tomas J. Philipson & Dana Goldman, 2007. "Integrated Insurance Design in the Presence of Multiple Medical Technologies," American Economic Review, American Economic Association, vol. 97(2), pages 427-432, May.
  37. Tomas Philipson & Anupam B. Jena & Eric Sun, 2007. "The institute of medicine report on the FDA: where is the science?," Health Economics, John Wiley & Sons, Ltd., vol. 16(3), pages 219-221, March.
  38. Darius Lakdawalla & Tomas Philipson, 2007. "Labor Supply and Weight," Journal of Human Resources, University of Wisconsin Press, vol. 42(1).
  39. Lakdawalla, Darius & Philipson, Tomas, 2006. "The nonprofit sector and industry performance," Journal of Public Economics, Elsevier, vol. 90(8-9), pages 1681-1698, September.
  40. Philipson Tomas J & Jena Anupam B, 2006. "Who Benefits from New Medical Technologies? Estimates of Consumer and Producer Surpluses for HIV/AIDS Drugs," Forum for Health Economics & Policy, De Gruyter, vol. 9(2), pages 1-33, January.
  41. Gary S. Becker & Tomas J. Philipson & Rodrigo R. Soares, 2005. "The Quantity and Quality of Life and the Evolution of World Inequality," American Economic Review, American Economic Association, vol. 95(1), pages 277-291, March.
  42. Darius Lakdawalla & Tomas Philipson & Jay Bhattacharya, 2005. "Welfare-Enhancing Technological Change and the Growth of Obesity," American Economic Review, American Economic Association, vol. 95(2), pages 253-257, May.
  43. Berndt Ernst R. & Gottschalk Adrian H. B. & Philipson Tomas & Strobeck Matthew W., 2005. "Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process," Forum for Health Economics & Policy, De Gruyter, vol. 8(1), pages 1-25, January.
  44. Pierre-Yves Geoffard & Tomas Philipson, 2002. "Pricing and R&D When Consumption Affects Longevity," RAND Journal of Economics, The RAND Corporation, vol. 33(1), pages 85-95, Spring.
  45. Frank R. Lichtenberg & Tomas J. Philipson, 2002. "The Dual Effects of Intellectual Property Regulations: Within- and Between-Patent Competition in the U.S. Pharmaceuticals Industry," Journal of Law and Economics, University of Chicago Press, vol. 45(S2), pages 643-672.
  46. Tomas J. Philipson, 2002. "The Regulation of Medical Innovation and Pharmaceutical Markets," Journal of Law and Economics, University of Chicago Press, vol. 45(S2), pages 583-586.
  47. Darius Lakdawalla & Tomas Philipson, 2002. "The Rise in Old-Age Longevity and the Market for Long-Term Care," American Economic Review, American Economic Association, vol. 92(1), pages 295-306, March.
  48. Philipson, Tomas, 2001. "Data Markets, Missing Data, and Incentive Pay," Econometrica, Econometric Society, vol. 69(4), pages 1099-1111, July.
  49. Philipson, Thomas, 2001. "Managed Care and the Quality of Health Care: A Misguided Debate?," The Journal of Legal Studies, University of Chicago Press, vol. 30(2), pages 753-758, June.
  50. Tomas Philipson, 2001. "The world‐wide growth in obesity: an economic research agenda," Health Economics, John Wiley & Sons, Ltd., vol. 10(1), pages 1-7, January.
  51. Lakdawalla Darius & Philipson Thomas, 2001. "Public Financing and the Market for Long-Term Care," Forum for Health Economics & Policy, De Gruyter, vol. 4(1), pages 1-19, January.
  52. Michael A. Boozer & Tomas J. Philipson, 2000. "The Impact of Public Testing for Human Immunodeficiency Virus," Journal of Human Resources, University of Wisconsin Press, vol. 35(3), pages 419-446.
  53. Tomas J. Philipson & William H. Dow & Xavier Sala-i-Martin, 1999. "Longevity Complementarities under Competing Risks," American Economic Review, American Economic Association, vol. 89(5), pages 1358-1371, December.
  54. Tomas Philipson & John Cawley, 1999. "An Empirical Examination of Information Barriers to Trade in Insurance," American Economic Review, American Economic Association, vol. 89(4), pages 827-846, September.
  55. Philipson, Tomas & Malani, Anup, 1999. "Measurement errors: A principal investigator-agent approach," Journal of Econometrics, Elsevier, vol. 91(2), pages 273-298, August.
  56. Tomas J. Philipson & Gary S. Becker, 1998. "Old-Age Longevity and Mortality-Contingent Claims," Journal of Political Economy, University of Chicago Press, vol. 106(3), pages 551-573, June.
  57. Tomas Philipson & Larry V. Hedges, 1998. "Subject Evaluation in Social Experiments," Econometrica, Econometric Society, vol. 66(2), pages 381-408, March.
  58. Philipson, Tomas & Lawless, Thomas, 1997. "Multiple-output agency incentives in data production: experimental evidence," European Economic Review, Elsevier, vol. 41(3-5), pages 961-970, April.
  59. Philipson, Tomas, 1997. "The evaluation of new health care technology: The labor economics of statistics," Journal of Econometrics, Elsevier, vol. 76(1-2), pages 375-395.
  60. Geoffard, Pierre-Yves & Philipson, Tomas, 1997. "Disease Eradication: Private versus Public Vaccination," American Economic Review, American Economic Association, vol. 87(1), pages 222-230, March.
  61. Tomas Philipson, 1997. "Data Markets and the Production of Surveys," The Review of Economic Studies, Review of Economic Studies Ltd, vol. 64(1), pages 47-72.
  62. Philipson, Tomas J & Snyder, James M, Jr, 1996. "Equilibrium and Efficiency in an Organized Vote Market," Public Choice, Springer, vol. 89(3-4), pages 245-265, December.
  63. Tomas J. Philipson & Richard A. Posner, 1996. "`Rational Choice, Public Policy And Aids'," Rationality and Society, , vol. 8(4), pages 498-502, November.
  64. Avner Ahituv & V. Joseph Hotz & Tomas Philipson, 1996. "The Responsiveness of the Demand for Condoms to the Local Prevalence of AIDS," Journal of Human Resources, University of Wisconsin Press, vol. 31(4), pages 869-897.
  65. Philipson, Tomas J & Posner, Richard A, 1996. "The Economic Epidemiology of Crime," Journal of Law and Economics, University of Chicago Press, vol. 39(2), pages 405-433, October.
  66. Geoffard, Pierre-Yves & Philipson, Tomas, 1996. "Rational Epidemics and Their Public Control," International Economic Review, Department of Economics, University of Pennsylvania and Osaka University Institute of Social and Economic Research Association, vol. 37(3), pages 603-624, August.
  67. Dow, William H. & Philipson, Tomas, 1996. "An empirical examination of the implications of assortative matching on the incidence of HIV," Journal of Health Economics, Elsevier, vol. 15(6), pages 735-749, December.
  68. Tomas Philipson, 1996. "Private Vaccination and Public Health: An Empirical Examination for U.S. Measles," Journal of Human Resources, University of Wisconsin Press, vol. 31(3), pages 611-630.
  69. Tomas J. Philipson & Richard A. Posner, 1995. "A Theoretical and Empirical Investigation of the Effects of Public Health Subsidies for STD Testing," The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 110(2), pages 445-474.
  70. Philipson, Tomas, 1995. "The welfare loss of disease and the theory of taxation," Journal of Health Economics, Elsevier, vol. 14(3), pages 387-395, August.
  71. Philipson, Tomas & Posner, Richard A, 1994. "Public Spending on AIDS Education: An Economic Analysis," Journal of Law and Economics, University of Chicago Press, vol. 37(1), pages 17-38, April.
  72. Philipson Tomas, 1993. "Social Welfare and Measurement of Segregation," Journal of Economic Theory, Elsevier, vol. 60(2), pages 322-334, August.
  73. Tomas Philipson, 1992. "Desegregation and Social Monopoly Pricing," Rationality and Society, , vol. 4(2), pages 189-198, April.
  74. James J. Heckman & Thomas J. Philipson, 1992. "Evaluating an Argument for Affirmative Action," Rationality and Society, , vol. 4(3), pages 360-364, July.
  75. Tomas Philipson, 1991. "Dynamic information release," Journal of Economics, Springer, vol. 53(2), pages 205-213, June.

Chapters

  1. Tomas J. Philipson, 2018. "The Economic Value and Pricing of Personalized Medicine," NBER Chapters, in: Economic Dimensions of Personalized and Precision Medicine, pages 9-19, National Bureau of Economic Research, Inc.
  2. Peter J. Huckfeldt & Darius N. Lakdawalla & Tomas J. Philipson, 2012. "Economics of Obesity," Chapters, in: Andrew M. Jones (ed.), The Elgar Companion to Health Economics, Second Edition, chapter 7, Edward Elgar Publishing.
  3. Tomas J. Philipson & Eric Sun & Dana Goldman, 2010. "The Effects of Product Liability Exemption in the Presence of the FDA," NBER Chapters, in: Regulation vs. Litigation: Perspectives from Economics and Law, pages 137-163, National Bureau of Economic Research, Inc.
  4. Anupam B. Jena & John E. Calfee & Edward C. Mansley & Tomas J. Philipson, 2009. ""Me-Too" Innovation in Pharmaceutical Markets," NBER Chapters, in: Frontiers in Health Policy Research, volume 12, National Bureau of Economic Research, Inc.
  5. Ernst R. Berndt & Adrian H. B. Gottschalk & Tomas Philipson & Matthew W. Strobeck, 2005. "Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process," NBER Chapters, in: Frontiers in Health Policy Research, Volume 8, National Bureau of Economic Research, Inc.
  6. Anup Malani & Tomas Philipson & Guy David, 2003. "Theories of Firm Behavior in the Nonprofit Sector. A Synthesis and Empirical Evaluation," NBER Chapters, in: The Governance of Not-for-Profit Organizations, pages 181-216, National Bureau of Economic Research, Inc.
  7. John Cawley & Tomas Philipson, 2002. "A direct test of the 'lemons' model: the market for used pickup trucks," Chapters, in: Tyler Cowen & Eric Crampton (ed.), Market Failure or Success, chapter 13, Edward Elgar Publishing.
  8. Darius Lakdawalla & Tomas Philipson, 2001. "Public Financing and the Market for Long-Term Care," NBER Chapters, in: Frontiers in Health Policy Research, Volume 4, pages 77-94, National Bureau of Economic Research, Inc.
  9. Tomas Philipson & Darius Lakdawalla, 2001. "Medical Care Output and Productivity in the Nonprofit Sector," NBER Chapters, in: Medical Care Output and Productivity, pages 119-140, National Bureau of Economic Research, Inc.
  10. Tomas Philipson, 2000. "Asymmetric Information and the Not-for-Profit Sector Does Its Output Sell a a Premium?," NBER Chapters, in: The Changing Hospital Industry: Comparing Not-for-Profit and For-Profit Institutions, pages 325-356, National Bureau of Economic Research, Inc.
  11. Philipson, Tomas, 2000. "Economic epidemiology and infectious diseases," Handbook of Health Economics, in: A. J. Culyer & J. P. Newhouse (ed.), Handbook of Health Economics, edition 1, volume 1, chapter 33, pages 1761-1799, Elsevier.

Books

  1. Tomas J. Philipson & Anupam B. Jena & Eric C. Sun, 2010. "Health and Wealth Disparities in the United States," Books, American Enterprise Institute, number 50896, September.

More information

Research fields, statistics, top rankings, if available.

Statistics

Access and download statistics for all items

Rankings

This author is among the top 5% authors according to these criteria:
  1. Average Rank Score
  2. Number of Works
  3. Number of Distinct Works
  4. Number of Distinct Works, Weighted by Simple Impact Factor
  5. Number of Distinct Works, Weighted by Recursive Impact Factor
  6. Number of Distinct Works, Weighted by Number of Authors
  7. Number of Distinct Works, Weighted by Number of Authors and Simple Impact Factors
  8. Number of Distinct Works, Weighted by Number of Authors and Recursive Impact Factors
  9. Number of Citations
  10. Number of Citations, Discounted by Citation Age
  11. Number of Citations, Weighted by Simple Impact Factor
  12. Number of Citations, Weighted by Simple Impact Factor, Discounted by Citation Age
  13. Number of Citations, Weighted by Recursive Impact Factor
  14. Number of Citations, Weighted by Recursive Impact Factor, Discounted by Citation Age
  15. Number of Citations, Weighted by Number of Authors
  16. Number of Citations, Weighted by Number of Authors, Discounted by Citation Age
  17. Number of Citations, Weighted by Number of Authors and Simple Impact Factors
  18. Number of Citations, Weighted by Number of Authors and Simple Impact Factors, Discounted by Citation Age
  19. Number of Citations, Weighted by Number of Authors and Recursive Impact Factors
  20. Number of Citations, Weighted by Number of Authors and Recursive Impact Factors, Discounted by Citation Age
  21. h-index
  22. Number of Registered Citing Authors
  23. Number of Registered Citing Authors, Weighted by Rank (Max. 1 per Author)
  24. Number of Journal Pages
  25. Number of Journal Pages, Weighted by Simple Impact Factor
  26. Number of Journal Pages, Weighted by Recursive Impact Factor
  27. Number of Journal Pages, Weighted by Number of Authors
  28. Number of Journal Pages, Weighted by Number of Authors and Simple Impact Factors
  29. Number of Journal Pages, Weighted by Number of Authors and Recursive Impact Factors
  30. Euclidian citation score
  31. Closeness measure in co-authorship network
  32. Breadth of citations across fields
  33. Wu-Index
  34. Record of graduates

Co-authorship network on CollEc

Featured entries

This author is featured on the following reading lists, publication compilations, Wikipedia, or ReplicationWiki entries:
  1. Technology Assessment

NEP Fields

NEP is an announcement service for new working papers, with a weekly report in each of many fields. This author has had 33 papers announced in NEP. These are the fields, ordered by number of announcements, along with their dates. If the author is listed in the directory of specialists for this field, a link is also provided.
  1. NEP-HEA: Health Economics (25) 1998-09-14 1999-03-01 1999-04-27 2003-06-16 2004-08-31 2004-11-22 2005-11-05 2005-12-09 2005-12-09 2006-01-24 2006-02-26 2007-08-27 2007-11-03 2008-05-31 2008-07-14 2009-12-19 2011-05-14 2012-12-15 2013-05-11 2013-05-24 2013-09-24 2014-05-17 2014-08-02 2017-01-01 2017-05-21. Author is listed
  2. NEP-INO: Innovation (10) 1999-12-08 2005-12-09 2005-12-09 2006-01-24 2006-02-26 2006-10-21 2011-05-14 2014-05-17 2017-01-01 2017-05-21. Author is listed
  3. NEP-IAS: Insurance Economics (4) 2007-02-10 2007-08-27 2007-09-02 2013-05-11
  4. NEP-COM: Industrial Competition (3) 2006-04-22 2006-10-21 2017-01-01
  5. NEP-PUB: Public Finance (3) 1998-09-14 2000-05-16 2000-10-31
  6. NEP-REG: Regulation (3) 2005-11-05 2006-04-22 2007-11-03
  7. NEP-AGR: Agricultural Economics (2) 1999-04-27 2007-11-03
  8. NEP-HAP: Economics of Happiness (2) 2008-05-31 2008-07-14
  9. NEP-LAW: Law and Economics (2) 2004-11-22 2006-04-22
  10. NEP-LTV: Unemployment, Inequality and Poverty (2) 2003-06-16 2007-08-27
  11. NEP-PBE: Public Economics (2) 2005-11-05 2005-12-09
  12. NEP-AFR: Africa (1) 2005-12-09
  13. NEP-BEC: Business Economics (1) 2013-05-24
  14. NEP-CSE: Economics of Strategic Management (1) 2009-06-17
  15. NEP-DEV: Development (1) 2003-06-16
  16. NEP-EFF: Efficiency and Productivity (1) 2017-01-01
  17. NEP-ENV: Environmental Economics (1) 1999-04-27
  18. NEP-IND: Industrial Organization (1) 2006-04-22
  19. NEP-MAC: Macroeconomics (1) 2013-05-24
  20. NEP-MKT: Marketing (1) 2006-10-21
  21. NEP-PKE: Post Keynesian Economics (1) 1999-03-08
  22. NEP-SOC: Social Norms and Social Capital (1) 2007-08-27
  23. NEP-TID: Technology and Industrial Dynamics (1) 2017-01-01

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, Tomas J Philipson should log into the RePEc Author Service.

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.

IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.